SEC 13F Intelligence

Vivo Capital, LLC / AKRO

Vivo Capital, LLC’s Akero Therapeutics Inc Com Position

Does Vivo Capital, LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 434.7K shares worth $21M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$21M
Q3 2025
Shares
434.7K
% of Portfolio
+1.66%
Quarters Held
8
position exited

Position History AKRO

Reported value by quarter
Q1 ’20: $17MQ1 ’20Q2 ’20: $15MQ2 ’20Q3 ’20: $15MQ3 ’20Q4 ’20: $16MQ4 ’20Q1 ’21: $20MQ1 ’21Q1 ’25: $8MQ1 ’25Q2 ’25: $23MQ2 ’25Q3 ’25: $21MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025434.7K$21M+1.66%
Q2 2025434.7K$23M+2.37%
Q1 2025201.2K$8M+1.08%
Q1 2021673.3K$20M+0.69%
Q4 2020633.4K$16M+0.73%
Q3 2020591.2K$15M+1.06%
Q2 2020591.2K$15M+1.06%
Q1 2020808.2K$17M+1.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vivo Capital, LLC’s full portfolio or all institutional holders of AKRO.